Genzyme (GENZ) Offers FY09 Earnings/Drug Sales Guidance
Tweet Send to a Friend
Genzyme (Nasdaq: GENZ) is offering a '09 outlook:
Sees FY09 sales of $5.15-$5.35 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Sees FY09 sales of $5.15-$5.35 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
